'Immune activation' diaporamas de présentation

Inflammation Chronic inflammation and aging Why? Inflammation, immune activation and HIV infection

1.1k views • 74 slides

The role of innate immunity in the pathogenesis of Serious Non-AIDS Events

593 views • 41 slides

Cryptococcal IRIS in Africa: clinical manifestations and pathogenesis

Cryptococcal IRIS in Africa: clinical manifestations and pathogenesis. Paul R. Bohjanen, M.D., Ph.D. Associate Professor of Microbiology and Medicine University of Minnesota Minneapolis, MN, USA Professor in Residence Infectious Diseases Institute Makerere University Kampala, Uganda.

578 views • 41 slides

Williams 2001

Thyroid Disease in Pregnancy. Williams 2001. Hyperthyroidism Subclinical thyotoxicosis Hypothyroidism Subclinical hypothyroidism Nodular thyroid disease Postpartum thyroiditis. contents. Sporadic nontoxic goiter = 5% Hyperthyroidism = 1%

552 views • 37 slides

FEVER

FEVER. DENGUE VIRUS: NO ONE IS SAFE. Prepared by: Mohamed Abdul Gader. Alternative Names. West Nile Fever Break Bone Fever Dengue like Disease Onyong- Nyang Fever. WHAT IS DENGUE ?. Dengue is an arthropod-borne disease caused by any one of four closely related viruses.

718 views • 37 slides

XVIII International AIDS Conference, July 19, 2010

HIV Pathogenesis Update 2010: Immune Activation & Inflammation Richard Jefferys Coordinator, Michael Palm Basic Science, Vaccines & Prevention Project, Treatment Action Group richard.jefferys@treatmentactiongroup.org. XVIII International AIDS Conference, July 19, 2010. What is Immune Activation?.

443 views • 33 slides

HIV Pathogenesis: Immune Activation & Inflammation

HIV Pathogenesis: Immune Activation & Inflammation. HIV Research Catalyst Forum, April 21 2010. What is Immune Activation?. Normally a transient phenomenon, as with the flu or any other acute infection All the signs of activation happen, but only for a week or two

575 views • 33 slides

Immunomodulation and cancer: Different relationships across diseases and disease states?

Immunomodulation and cancer: Different relationships across diseases and disease states?. Rafael Ponce Sept 27, 2012. Immunomodulation and cancer. Virus. Immune function. Tumor. Immune escape mechanisms

506 views • 27 slides

New concepts in HIV Immunology

454 views • 27 slides

Immunology of HIV: What can we learn from LTNPs / Elite Controlers ?

551 views • 25 slides

HIV Translational Research Unit - HTRU

Clinical studies set-up Characterization of HIV viral reservoir and quantification of HIV DNA and RNA in patients >12 months on Combined Antiretroviral Therapy Linos Vandekerckhove , University Ghent. HIV Translational Research Unit - HTRU. Contents. Background Study hypothesis

305 views • 23 slides

CD4+ memory stem cells (T SCM ) in pathogenic and non-pathogenic SIV infections

CD4+ memory stem cells (T SCM ) in pathogenic and non-pathogenic SIV infections . Guido Silvestri, MD Yerkes National Primate Research Center Emory University School of Medicine Emory Center for AIDS Research (CFAR) Emory Vaccine Center.

384 views • 22 slides

Pathogenesis of HIV disease and markers of progression

Pathogenesis of HIV disease and markers of progression. Anjie Zhen, PhD 8.6.2013. Summary. Overview of HIV life cycle Overview human immune responses HIV pathogenesis Acquisition of HIV Acute infection Chronic infection and markers of progression AIDS. Overview of HIV life cycle.

816 views • 21 slides

Microbial Translocation and HIV/SIV Infections

445 views • 20 slides

Clinical Trials Panel

Clinical Trials Panel. Savita Pahwa, MD Director, Miami Center for AIDS Research University of Miami Miller School of Medicine, Miami FL. Disclosures of Financial Relationships. This speaker has no significant financial relationships with commercial entities to disclose.

259 views • 19 slides

TREG CHARACTERIZATION IN NORMAL AND SIV - INFECTED NON-HUMAN PRIMATES

TREG CHARACTERIZATION IN NORMAL AND SIV - INFECTED NON-HUMAN PRIMATES. Background Tregs suppress T-cell activation and proliferation in vitro and in vivo in both mice and humans.

256 views • 18 slides

M. Nikolova 1 , M. Muhtarova 1 , M. Younas 2 , J.D. Lelievre 2,3 , H. Taskov 1 , Y. Levy 2,3

Treg exert differential effects on the proliferation and differentiation of CD8 T cell subsets in chronic HIV-1 infection. M. Nikolova 1 , M. Muhtarova 1 , M. Younas 2 , J.D. Lelievre 2,3 , H. Taskov 1 , Y. Levy 2,3. 1 National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria

297 views • 16 slides

Introduction

The Pyk2 and c-Src protein tyrosine kinases play protective roles in early HIV-1 infection of CD4 + T-cells .

105 views • 1 slides

Introduction

Soluble tissue factor in Primary HIV Infection. Elizabeth Hamlyn 1,2 , Kiran Parmar 3 , Stephen Hickling 4 , John Frater 4 , Rodney Phillips 4 , Myra McClure 1 , Sarah Fidler 1 , and Beverley J Hunt 3 for the SPARTAC Investigators

153 views • 1 slides

Introduction

Soluble tissue factor in Primary HIV Infection. Elizabeth Hamlyn 1,2 , Kiran Parmar 3 , Stephen Hickling 4 , John Frater 4 , Rodney Phillips 4 , Myra McClure 1 , Sarah Fidler 1 , and Beverley J Hunt 3 for the SPARTAC Investigators

129 views • 1 slides